Oldest pages

Jump to navigation Jump to search

Showing below up to 50 results in range #4,601 to #4,650.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Section 4.3: Targeting the CSC microenvironment (from DOI: 10.1038/s41392-020-0110-5)‏‎ (12:02, 23 May 2020)
  2. Section 5: Conclusions and perspectives (from DOI: 10.1038/s41392-020-0110-5)‏‎ (12:04, 23 May 2020)
  3. Competing interests (from DOI: 10.1038/s41392-020-0110-5)‏‎ (12:04, 23 May 2020)
  4. Section 4.4: CSC-directed immunotherapy (from DOI: 10.1038/s41392-020-0110-5)‏‎ (13:18, 23 May 2020)
  5. Section 3.3: The microenvironment of CSCs (from DOI: 10.1038/s41392-020-0110-5)‏‎ (13:46, 23 May 2020)
  6. Section 4.1: Agents targeting CSC-associated surface biomarkers in clinical trials (from DOI: 10.1038/s41392-020-0110-5)‏‎ (14:28, 23 May 2020)
  7. Anthony SJ, et al, mBio (2013), cited as Ref 1 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  8. Woolhouse M, et al, Philos. Trans. R. Soc. B Biol. Sci. (2012), cited as Ref 2 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  9. Jones KE, et al, Nature (2008), cited as Ref 3 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  10. Vijayanand P, et al, Clin. Med. (2004), cited as Ref 4 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  11. Rather IA, et al, Front. Microbiol. (2017), cited as Ref 5 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  12. Hui DS, et al, Int. J. Infect. Dis. (2020), cited as Ref 6 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  13. Beal SG, et al, J. Clin. Microbiol. (2017), cited as Ref 7 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  14. Beck, et al, Future Microbiol. (2010), cited as Ref 8 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  15. Schlaberg R, et al, Arch. Pathol. Lab. Med. (2017), cited as Ref 9 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  16. Arnold JC, et al, Pediatrics (2008), cited as Ref 10 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  17. Vu D-L, et al, Viruses (2019), cited as Ref 11 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  18. Kennedy P, et al, Viruses (2017), cited as Ref 12 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  19. Abdel-Hamid M, et al, J. Clin. Microbiol. (2002), cited as Ref 13 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  20. Doller G, et al, J. Clin. Microbiol. (1992), cited as Ref 14 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  21. Hammond GW, et al, J. Infect. Dis. (1980), cited as Ref 15 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  22. Kasprowicz V, et al, J. Clin. Investig. (2008), cited as Ref 16 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  23. Hoofnagle AN, et al, J. Immunol. M, ethods (2009), cited as Ref 17 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  24. Cogswell FB, et al, J. Clin. Microbiol. (1996), cited as Ref 18 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  25. Reyes GR, et al, Mol. Cell. Probes (1991), cited as Ref 19 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  26. Castrignano SB, et al, Virus Res. (2013), cited as Ref 20 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  27. DePew J, et al, Virol. J. (2013), cited as Ref 21 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  28. Djikeng A, et al, BMC Genom. (2008), cited as Ref 22 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  29. Ambrose HE, et al, Rev. Med. Virol. (2006), cited as Ref 23 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  30. De Vries M, et al, PLoS ONE (2011), cited as Ref 24 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  31. VanDevanter DR, et al, J. Clin. Microbiol. (1996), cited as Ref 25 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  32. Weiss S, et al, Emerg. Infect. Dis. (2012), cited as Ref 26 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  33. Drosten C, et al, N. Engl. J. Med. (2003), cited as Ref 27 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  34. Zheng L, et al, J. Virol. M, ethods (2015), cited as Ref 28 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  35. Choi SK, et al, J. Virol. M, ethods (1999), cited as Ref 29 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  36. Proebster B, et al, Am. J. Trop. Med. Hyg. (1997), cited as Ref 30 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  37. Radford AD, et al, J. Gen. Virol. (2012), cited as Ref 31 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  38. Jerome H, et al, J. Infect. (2019), cited as Ref 32 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  39. Prachayangprecha S, et al, J. Clin. Microbiol. (2014), cited as Ref 33 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  40. Dhiman N, et al, Expert Rev. Vaccines (2009), cited as Ref 34 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  41. Luciani F, et al, Trends Biotechnol. (2012), cited as Ref 35 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  42. Kruglyak KM, et al, Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management (2016), cited as Ref 36 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  43. Derache A, et al, Clin. Infect. Dis. (2019), cited as Ref 37 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  44. Riley LW, et al, Microbiol. Spectr. (2018), cited as Ref 38 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  45. Wilson MR, et al, N. Engl. J. Med. (2019), cited as Ref 39 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  46. Sukhum KV, et al, Clin. Pharmacol. Ther. (2019), cited as Ref 40 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  47. Chen K, et al, PLoS Comput. Biol. (2005), cited as Ref 41 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  48. Worthey EA, et al, Gen, et. Med. (2011), cited as Ref 42 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  49. Li C-X, et al, eLife (2015), cited as Ref 43 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)
  50. Shi M, et al, Nature (2016), cited as Ref 44 in DOI: 10.3390/v12020211‏‎ (02:54, 24 May 2020)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:AncientPages"